FDA DEVICE FACTS
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)
Ever Fortune.Ai, Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
EFAI CHESTSUITE XR MALPOSITIONED ETT ASSESSMENT SYSTEM (EFAI ETTXR) is a radiological computer-aided triage and notification software indicated for use in the analysis of chest X-ray (CXR) images in adults. It is intended to assist workflow triage by flagging and communicating suspected vertically malpositioned endotracheal tube (ETT) relative to the carina. Findings are flagged when the ETT distal tip is more than 7 cm above, less than 3 cm above, or below the carina. It assesses solely vertical position, does not factor patient positioning, and cannot detect esophageal intubation. EFAI ETTXR uses deep learning algorithms and makes case-level output available for worklist prioritization or triage. It is not intended to direct attention to specific portions or anomalies of an image. Results are not intended for stand-alone clinical decision-making, to rule out malpositioned ETT, or to preclude clinical assessment.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。